Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy
…, F Paulsen, M Reimold, H Dittmann… - Journal of nuclear …, 2005 - Soc Nuclear Med
In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC),
hypoxia is known to be an important prognostic factor for long-term survival and local tumor …
hypoxia is known to be an important prognostic factor for long-term survival and local tumor …
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study
B Smyczek-Gargya, N Fersis, H Dittmann… - European journal of …, 2004 - Springer
The aim of this study was to evaluate the use of [ 18 F]fluorothymidine (FLT) as a positron
emission tomography (PET) tracer for the diagnosis of breast cancer. To this end, 12 patients …
emission tomography (PET) tracer for the diagnosis of breast cancer. To this end, 12 patients …
[18F]FLT PET for diagnosis and staging of thoracic tumours
H Dittmann, BM Dohmen, F Paulsen… - European journal of …, 2003 - Springer
The nucleoside analogue 3'-deoxy-3'-[ 18 F]fluorothymidine (FLT) has been introduced for
imaging of tumour cell proliferation by positron emission tomography (PET). This study …
imaging of tumour cell proliferation by positron emission tomography (PET). This study …
Early changes in [18F]FLT uptake after chemotherapy: an experimental study
H Dittmann, B Dohmen, R Kehlbach, G Bartusek… - European journal of …, 2002 - Springer
This study evaluated the use of 3′-deoxy-3′-[ 18 F]fluorothymidine ([ 18 F]FLT) for monitoring
of the early effects of anticancer chemotherapy on tumour cell proliferation. Cells derived …
of the early effects of anticancer chemotherapy on tumour cell proliferation. Cells derived …
[HTML][HTML] Independent attenuation correction of whole body [18F]FDG-PET using a deep learning approach with Generative Adversarial Networks
K Armanious, T Hepp, T Küstner, H Dittmann… - EJNMMI research, 2020 - Springer
Background Attenuation correction (AC) of PET data is usually performed using a second
imaging for the generation of attenuation maps. In certain situations however—when CT- or MR…
imaging for the generation of attenuation maps. In certain situations however—when CT- or MR…
Hybrid cardiac magnetic resonance/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis
…, H Mahrholdt, M Häntschel, J Hetzel, H Dittmann… - Cardiovascular …, 2022 - jacc.org
Objectives The purpose of this study was to investigate the diagnostic value of simultaneous
hybrid cardiac magnetic resonance (CMR) and 18 F-fluorodeoxyglucose positron emission …
hybrid cardiac magnetic resonance (CMR) and 18 F-fluorodeoxyglucose positron emission …
Safety and survival outcomes of 177Lu-prostate-specific membrane antigen therapy in patients with metastatic castration-resistant prostate cancer with prior 223Ra …
…, V Prasad, P Rassek, E Hasa, H Dittmann… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The radium lutetium (RALU) study evaluated the feasibility of sequential α- and β-emitter use
in patients with bone-predominant metastatic castration-resistant prostate cancer. Methods: …
in patients with bone-predominant metastatic castration-resistant prostate cancer. Methods: …
A prospective study of quantitative SPECT/CT for evaluation of lung shunt fraction before SIRT of liver tumors
H Dittmann, D Kopp, J Kupferschlaeger… - Journal of Nuclear …, 2018 - Soc Nuclear Med
The lung shunt fraction (LSF) is estimated using 99m Tc-macroaggregated albumin ( 99m Tc-MAA)
imaging before selective internal radiotherapy (SIRT) of the liver to reduce the risk of …
imaging before selective internal radiotherapy (SIRT) of the liver to reduce the risk of …
[PDF][PDF] Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas …
MÖ Öksüz, H Dittmann, C Wicke… - Diagnostic and …, 2011 - cms.dirjournal.org
PURPOSE To compare the accuracy of planar scintigraphy, single photon emission computed
tomography (SPECT), SPECT-CT, and positron emission tomography (PET) with C-11 …
tomography (SPECT), SPECT-CT, and positron emission tomography (PET) with C-11 …
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplantation in …
…, R Trenschel, V Vucinic, H Dittmann… - Blood, The Journal …, 2010 - ashpublications.org
Forty patients were enrolled in this phase 2 study combining radioimmunotherapy (RIT) using
yttrium-90-ibritumomab-tiuxetan (15 MBq [0.4 mCi]/kg) with reduced-intensity conditioning (…
yttrium-90-ibritumomab-tiuxetan (15 MBq [0.4 mCi]/kg) with reduced-intensity conditioning (…